Correlation Between Genomma Lab and Veritas Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genomma Lab and Veritas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genomma Lab and Veritas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genomma Lab Internacional and Veritas Pharma, you can compare the effects of market volatilities on Genomma Lab and Veritas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genomma Lab with a short position of Veritas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genomma Lab and Veritas Pharma.

Diversification Opportunities for Genomma Lab and Veritas Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Genomma and Veritas is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Genomma Lab Internacional and Veritas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Veritas Pharma and Genomma Lab is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genomma Lab Internacional are associated (or correlated) with Veritas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Veritas Pharma has no effect on the direction of Genomma Lab i.e., Genomma Lab and Veritas Pharma go up and down completely randomly.

Pair Corralation between Genomma Lab and Veritas Pharma

If you would invest  107.00  in Genomma Lab Internacional on September 12, 2024 and sell it today you would earn a total of  20.00  from holding Genomma Lab Internacional or generate 18.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Genomma Lab Internacional  vs.  Veritas Pharma

 Performance 
       Timeline  
Genomma Lab Internacional 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Genomma Lab Internacional are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Genomma Lab reported solid returns over the last few months and may actually be approaching a breakup point.
Veritas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Veritas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Veritas Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Genomma Lab and Veritas Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genomma Lab and Veritas Pharma

The main advantage of trading using opposite Genomma Lab and Veritas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genomma Lab position performs unexpectedly, Veritas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veritas Pharma will offset losses from the drop in Veritas Pharma's long position.
The idea behind Genomma Lab Internacional and Veritas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stocks Directory
Find actively traded stocks across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance